Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma.
Arthritis & Rheumatism, 1979Skin biopsies of uniform location and surface area (7 mm diameter) were obtained from the extensor aspect of the forearm of 147 patients with progressive systemic sclerosis (PSS) (107 with diffuse scleroderma, 40 with the CREST syndrome variant) and 58 ...
G. Rodnan, Esther Lipinski, J. Luksick
semanticscholar +1 more source
Muscle disease in progressive systemic sclerosis: diagnostic and therapeutic considerations.
Arthritis & Rheumatism, 1978Upon careful examination, 23 of 24 patients with progressive systemic sclerosis (PSS) were found to have abnormalities of muscle. Nineteen patients presented a homogenous pattern of muscle abnormalities, which untreated was associated with a stable ...
P. Clements +7 more
semanticscholar +1 more source
Neurologic Manifestations of Progressive Systemic Sclerosis
Archives of Neurology, 1992Neurologic involvement in progressive systemic sclerosis is considered uncommon. We retrospectively examined the prevalence and nature of neurologic complications in 50 patients with progressive systemic sclerosis. In 20 (40%), neurologic abnormalities were detected, with a total of 28 neurologic manifestations. All levels of the central and peripheral
Oded Abramsky +2 more
openaire +2 more sources
Mesenchymal Stem Cell–Based Therapy as a New Approach for the Treatment of Systemic Sclerosis
Clinical reviews in allergy and immunology, 2022X. Zhuang +5 more
semanticscholar +1 more source
Trigeminal neuropathy in progressive systemic sclerosis
The American Journal of Medicine, 1982Trigeminal neuropathy was identified in 16 (4 percent) of 442 consecutive patients with progressive systemic sclerosis (PSS) who were first evaluated during the period between 1972 and 1980. These cases, together with 25 others that are adequately documented in the literature, were reviewed and compared with the 426 cases of PSS (96 percent) without ...
Dorothy A. Farrell, Thomas A. Medsger
openaire +3 more sources
Progressive Systemic Sclerosis: Visceral Manifestations in Generalized Scleroderma
, 1955The visceral manifestations of scleroderma have been recognized for almost 60 years, but the relative infrequency of the disease and the difficulty of obtaining adequate pathological material have, with certain outstanding exceptions, precluded the ...
W. Piper, E. B. Helwig
semanticscholar +1 more source
Progressive Systemic Sclerosis (Scleroderma)
Postgraduate Medicine, 1962The term “progressive systemic sclerosis” is preferred to “scleroderma,” since the skin is not always involved at first and rarely is not involved at all, even in fatal cases. Organic involvement is widespread. There is no satisfactory treatment, but there are measures which moderate the inexorable and fatal course of the disease, and certainly ...
openaire +2 more sources
The use of JAK inhibitors in the treatment of progressive systemic sclerosis
Journal of the European Academy of Dermatology and Venereology, 2018S. Deverapalli, D. Rosmarin
semanticscholar +1 more source
Progressive systemic sclerosis and S-adenosylmethionine
Clinical Rheumatology, 1985ORIENTE P +5 more
openaire +3 more sources
Therapeutic Approaches to Systemic Sclerosis: Recent Approvals and Future Candidate Therapies
Clinical reviews in allergy and immunology, 2021A. Lescoat +5 more
semanticscholar +1 more source